VIRVir Biotechnology, Inc.
9.780USD+0.10%Mkt Cap: 1.65B $P/E: —3d ago
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical dev…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap1.65B $
Enterprise Value1.12B $
Revenue (TTM)303.23M $
Gross Profit66.49M $
Net Income (TTM)-437.99M $
Revenue/Share2.044 USD
Last Price9.780 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees367
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.70
PEG—
EV/EBITDA-4.18
EV/Revenue3.69
P/S5.14
P/B1.83
EPS (TTM)-1.67
EPS (Forward)-2.49
52W Range
4.25075% of range11.66
52W High11.66 USD
52W Low4.250 USD
Profitability
Gross Margin99.96%
Oper. Margin30.75%
EBITDA Margin-88.37%
Profit Margin-658.43%
ROE-57.23%
ROA-43.68%
Growth
Revenue Growth19582.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-391.78M $
CapEx (TTM)4.83M $
FCF Margin-12.82%
FCF Yield-2.35%
Net Debt-439.45M $
Net Debt/EBITDA1.64
Balance Sheet
Debt/Equity0.13
Current Ratio6.04
Quick Ratio5.67
Book Value/Sh5.041 USD
Cash/Share3.148 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)21.00 USD
Upside (mean)+114.7%
Target Range15.00 USD – 30.00 USD
$15.00+114.7% to mean$30.00
# Analysts9
Ownership
Shares Out.169.22M
Float129.79M
Insiders6.57%
Institutions84.26%
Short Interest
Short Ratio12.1d
Short % Float11.39%
Short % Out.11.25%
Shares Short19.04M
Short (prev mo.)19.19M
Technical
SMA 509.340 (+4.7%)
SMA 2008.282 (+18.1%)
Beta1.59
S&P 52W Chg18.16%
Avg Vol (30d)1.52M
Avg Vol (10d)1.37M
Technical Indicators
RSI (14)62.4
MACD0.0459
MACD Signal-0.0719
MACD Hist.+0.1178
BB Upper9.692 USD
BB Middle9.030 USD
BB Lower8.369 USD
BB Width14.65%
ATR (14)0.4379 USD
Vol Ratio (20d)1.18x